Citation Impact
59 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Stuart Turner being referenced
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
2021 Standout
Author Peers
| Author | CCM | PRM | Oncology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Stuart Turner | 360 | 321 | 182 | 42 | 1.0k | |
| Justin M. Wolter | 4 | 1 | 9 | 19 | 366 | |
| H. H. Boer | 10 | 5 | 12 | 36 | 1.1k | |
| Paulo Casal | 1 | 1 | 9 | 627 | ||
| Curtis S. Cooper | 8 | 801 | ||||
| Jeongin Seo | 11 | 179 |
All Works
Loading papers...